Inhibitors of proliferation of mesangial cells, for example, leukotriene
antagonists, may offer therapeutic options for the treatment of proliferative glomerular diseases .
Combination therapy with a long acting beta-agonist and a leukotriene
antagonist in moderate asthma.
receptor antagonists in the treatment of asthma: An update.
It may also be effective for EC treatment due to its selective inhibition on leukotriene
receptor mediated response.
His team also found that deleting the receptors on immune cells that bind to leukotriene
B4 had a similar effect.
inhibitors (montelukast and zafirlukast) and 5-lipoxygenase inhibitor (zileuton) improve airway function primarily by blocking the inflammatory effects of various leukotrienes
A study found that tablet drugs called leukotriene
receptor antagonists (LTRAs) alleviated mild asthma just as well as steroid inhalers.
The tablets, called leukotriene
receptor antagonists, are currently recommended as third or fourth steps in asthma treatment because of the belief that they are less effective.
Pathophysiological role of mast cells in collagen-induced arthritis: Study with a cysteinyl leukotriene
receptor antagonist, montelukast.
The goalposts have changed recently with the addition of long-acting beta 2 agents such as salmeterol and the recent advent of leukotriene
We conducted a prospective, randomized, placebo-controlled, double-blind study to determine if the leukotriene
inhibitor montelukast is effective in eliminating persistent middle ear drainage in patients with otitis media with effusion (OME).
Clinical trials in adults have shown that combining ICS with a long-acting beta-agonist such as salmeterol produces greater lung function improvements than combining the ICS with the leukotriene
antagonist montelukast, Dr.